Turkmen, DursunAltunisik, NihalAltunisik Toplu, Sibel2024-08-042024-08-0420221473-21301473-2165https://doi.org/10.1111/jocd.14976https://hdl.handle.net/11616/100604[Abstract Not Available]eninfo:eu-repo/semantics/openAccessherpes zoster reactivationinactivated SARS-CoV-2 vaccinevaricella-zoster virusCommentary on Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccinationLetter218362736283539022110.1111/jocd.149762-s2.0-85128218609Q2WOS:000780847800001Q3